1R5I: MAM-MHC complex
Crystal structure of the MAM-MHC complex. Determined by X-ray diffraction at 2.6 Å resolution. Released 16 Mar 2004.
- Method
- X-ray diffraction
- Resolution
- 2.6 Å
- Organisms
- Homo sapiens, Mycoplasma arthritidis
- Chains
- 8
- Atoms
- 10,014
- Mol. weight
- 141.19 kDa
- Ligands
- PO4
- Released
- 16 Mar 2004
Explore 1R5I in 3D
Show helices and sheets
RCSB PDB
PDBe
Secondary structure: helices and β-sheets
1R5I contains 44 α-helices and 64 β-strands across 8 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.
Chains A and E: 3 helices, 16 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 5-15 | 11 | 1 |
| β-strand | 19-26 | 8 | 1 |
| β-strand | 29-35 | 7 | 1 |
| β-strand | 40-43 | 4 | 1 |
| α-helix | 46-49 | 4 | |
| β-strand | 53 | 1 | 2 |
| α-helix | 56-76 | 21 | |
| α-helix | 80-84 | 5 | |
| β-strand | 85 | 1 | 3 |
| β-strand | 88-93 | 6 | 4 |
| β-strand | 103-112 | 10 | 4 |
| β-strand | 113 | 1 | 3 |
| β-strand | 118-123 | 6 | 5 |
| β-strand | 126-128 | 3 | 5 |
| β-strand | 133-134 | 2 | 4 |
| β-strand | 138-139 | 2 | 4 |
| β-strand | 145-153 | 9 | 4 |
| β-strand | 161-166 | 6 | 5 |
| β-strand | 174-178 | 5 | 5 |
Chain B: 6 helices, 15 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 7-18 | 12 | 1 |
| β-strand | 23-32 | 10 | 1 |
| β-strand | 35-41 | 7 | 1 |
| β-strand | 47-49 | 3 | 1 |
| α-helix | 52-54 | 3 | |
| α-helix | 55-62 | 8 | |
| α-helix | 65-74 | 10 | |
| α-helix | 75-80 | 6 | |
| α-helix | 81-86 | 6 | |
| α-helix | 87-89 | 3 | |
| β-strand | 95 | 1 | 6 |
| β-strand | 98-104 | 7 | 7 |
| β-strand | 114-122 | 9 | 7 |
| β-strand | 123 | 1 | 6 |
| β-strand | 128-133 | 6 | 8 |
| β-strand | 136-138 | 3 | 8 |
| β-strand | 142-144 | 3 | 7 |
| β-strand | 148-149 | 2 | 7 |
| β-strand | 155-162 | 8 | 7 |
| β-strand | 170-176 | 7 | 8 |
| β-strand | 184-189 | 6 | 8 |
Chain C: 1 helix, 1 β-strand
| Element | Residues | Length | Sheet |
|---|
| β-strand | 307 | 1 | 2 |
| α-helix | 315-317 | 3 | |
Chains D and H: 12 helices, 0 β-strands
| Element | Residues | Length | Sheet |
|---|
| α-helix | 24-25 | 2 | |
| α-helix | 26-33 | 8 | |
| α-helix | 39-41 | 3 | |
| α-helix | 42-66 | 25 | |
| α-helix | 72-92 | 21 | |
| α-helix | 97-123 | 27 | |
| α-helix | 126-145 | 20 | |
| α-helix | 158-166 | 9 | |
| α-helix | 171-175 | 5 | |
| α-helix | 177-194 | 18 | |
| α-helix | 200-202 | 3 | |
| α-helix | 205-210 | 6 | |
Chain F: 5 helices, 15 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 7-18 | 12 | 9 |
| β-strand | 23-32 | 10 | 9 |
| β-strand | 35-41 | 7 | 9 |
| β-strand | 47-49 | 3 | 9 |
| α-helix | 52-54 | 3 | |
| α-helix | 55-62 | 8 | |
| α-helix | 65-74 | 10 | |
| α-helix | 75-80 | 6 | |
| α-helix | 81-86 | 6 | |
| β-strand | 95 | 1 | 14 |
| β-strand | 98-104 | 7 | 15 |
| β-strand | 114-122 | 9 | 15 |
| β-strand | 123 | 1 | 14 |
| β-strand | 128-133 | 6 | 16 |
| β-strand | 136-138 | 3 | 16 |
| β-strand | 142-144 | 3 | 15 |
| β-strand | 148-149 | 2 | 15 |
| β-strand | 155-162 | 8 | 15 |
| β-strand | 170-176 | 7 | 16 |
| β-strand | 184-189 | 6 | 16 |
Chain G: 2 helices, 1 β-strand
| Element | Residues | Length | Sheet |
|---|
| β-strand | 307 | 1 | 10 |
| α-helix | 311-313 | 3 | |
| α-helix | 315-317 | 3 | |
Molecules and chains
| Molecule | Chains | Type | Length | Organism | UniProt |
|---|
| HLA class II histocompatibility antigen, DR alpha chain | A, E | protein | 181 | Homo sapiens | P01903 (AlphaFold model) |
| HLA class II histocompatibility antigen, DRB1-1 beta chain | B, F | protein | 190 | Homo sapiens | P01911 (AlphaFold model) |
| Hemagglutinin peptide | C, G | protein | 13 | | P11133 |
| superantigen | D, H | protein | 216 | Mycoplasma arthritidis | Q48898 (AlphaFold model) |
Sequence of entity 1 (A, E), FASTA
>1R5I_1 HLA class II histocompatibility antigen, DR alpha chain (chains A, E)
IKEEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGAL
ANIAVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVT
WLRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEF
D
Sequence of entity 2 (B, F), FASTA
>1R5I_2 HLA class II histocompatibility antigen, DRB1-1 beta chain (chains B, F)
GDTRPRFLWQLKFECHFFNGTERVRLLERCIYNQEESVRFDSDVGEYRAVTELGRPDAEY
WNSQKDLLEQRRAAVDTYCRHNYGVGESFTVQRRVEPKVTVYPSKTQPLQHHNLLVCSVS
GFYPGSIEVRWFRNGQEEKAGVVSTGLIQNGDWTFQTLVMLETVPRSGEVYTCQVEHPSV
TSPLTVEWRA
Sequence of entity 3 (C, G), FASTA
>1R5I_3 Hemagglutinin peptide (chains C, G)
PKYVKQNTLKLAT
Sequence of entity 4 (D, H), FASTA
>1R5I_4 superantigen (chains D, H)
LGSMKLRVENPKKAQKHFVQNLNNVVFTNKELEDIYNLSNKEETKEVLKLFKLKVNQFYR
HAFGIVNDYNGLLEYKEIFNMMFLKLSVVFDTQRKEANNVEQIKRNIAILDEIMAKADND
LSYFISQNKNFQELWDKAVKLTKEMKIKLKGQKLDLRDGEVAINKVRELFGSDKNVKELW
WFRSLLVKGVYLIKRYYEGDIELKTTSDFAKAVFED
Ligands and cofactors
| ID | Name | Formula | Copies |
|---|
| PO4 | Phosphate ion | O4 P | 4 |
Primary citation
Crystal structure of Mycoplasma arthritidis mitogen complexed with HLA-DR1 reveals a novel superantigen fold and a dimerized superantigen-MHC complex. Zhao, Y., Li, Z., Drozd, S.J. et al. Structure (2004) 12:277-288. DOI 10.1016/S0969-2126(04)00020-6 · PubMed
Other PDB entries of the same protein (UniProt P01903 (AlphaFold model), which also has an AlphaFold model), best resolution first:
- 5NI9 1.33 Å, Crystal structure of HLA-DRB1*04:01 with the alpha-enolase peptide 326-340
- 4X5W 1.34 Å, HLA-DR1 with CLIP102-120(M107W)
- 5NIG 1.35 Å, Crystal structure of HLA-DRB1*04:01 with modified alpha-enolase peptide 326-340…
- 8CMC 1.42 Å, Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S511-530
- 8PJF 1.48 Å, Human Leukocyte Antigen class II allotype DR1 presenting P11T->R modified influenza A…
- 6QZC 1.64 Å, HLA-DR1 with the QAR Peptide
- 8CMG 1.64 Å, Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 nsp14 peptide…
- 8CMH 1.64 Å, Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Omicron (BA.1) Spike…
- 4MD5 1.65 Å, Immune Receptor
- 4MDJ 1.7 Å, Immune Receptor
- 8PJE 1.7 Å, Human Leukocyte Antigen class II allotype DR1 presenting influenza A virus…
- 7YX9 1.76 Å, MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange
Browse structure collections
About this viewer
MolViewer shows 1R5I directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.